News

North West Devt Commission plans $200m MOU on agric

  • Post author:
  • Post category:News
  • Post comments:0 Comments
  • Post last modified:September 7, 2025

The North West Development Commission over the weekend began the process for the signing of a Memorandum of Understanding on Agriculture Development and Commercial farming in the region that would…

Big job awaits PM

  • Post author:
  • Post category:News
  • Post comments:0 Comments
  • Post last modified:September 7, 2025

Thailand has a new prime minister. Anutin Charnvirakul, leader of the Bhumjaithai Party, has assumed the premiership, the country's third in less than three years since the 2023 general election.…

‘Pilots, engineers’ brain drain worrisome’

  • Post author:
  • Post category:News
  • Post comments:0 Comments
  • Post last modified:September 7, 2025

President of the National Association of Aircraft Pilots and Engineers (NAAPE), Comrade Abednego Galadima in a chat with our correspondent as the association marks its 40-year anniversary this year highlights…

Lilianfels’ major refurbishment

  • Post author:
  • Post category:News
  • Post comments:0 Comments
  • Post last modified:September 6, 2025

Beyond the accommodation, the resort will offer elevated dining, refreshed event spaces and enhanced wellness facilities, reinforcing its status as a premier destination in the Mountains. "Lilianfels has a unique…

Revive Therapeutics Announces Extension of Proposed Private Placement

  • Post author:
  • Post category:News
  • Post comments:0 Comments
  • Post last modified:September 5, 2025

TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics…

RCUS

  • Post author:
  • Post category:News
  • Post comments:0 Comments
  • Post last modified:September 5, 2025

Insider Sell: COO Jennifer Jarrett Sells 11,551 Shares of Arcus Biosciences Inc (RCUS) Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of immunotherapies.…